Inturrisi, Charles
Relmada Therapeutics, Inc.,
United States
2022 Rank: 36274
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Neurology & Neurosurgery
Rank in SubField 1: 312 out of 134745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 36274 | 39400 |
| Total Cites | 9537 | 10436 |
| H-index | 55 | 56 |
| Hm-index | 21 | 23 |
| Number of Single Authored Papers | 14 | 14 |
| Total Cites to Single Authored Papers | 211 | 227 |
| Number of Single+First Authored Papers | 42 | 42 |
| Total Cites to Single+First Authored Papers | 1437 | 1480 |
| Number of Single+First+Last Authored Papers | 180 | 180 |
| Total Cites to Single+First+Last Authored Papers | 5497 | 5990 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 7338 | 7739 |
| Ratio of Total Citations to Distinct Citing Papers | 1.30 | 1.35 |
| Self-Citation Percentage |
8.61%
|
|
Inturrisi, Charles
Weill Cornell Medicine,
United States
2020 Rank: 31985
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Neurology & Neurosurgery
SubField 2:
Anesthesiology
Rank in SubField 1: 2485 out of 227881 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 31985 | 33694 |
| Total Cites | 8945 | 9786 |
| H-index | 53 | 55 |
| Hm-index | 21 | 23 |
| Number of Single Authored Papers | 16 | 16 |
| Total Cites to Single Authored Papers | 199 | 214 |
| Number of Single+First Authored Papers | 46 | 46 |
| Total Cites to Single+First Authored Papers | 1359 | 1401 |
| Number of Single+First+Last Authored Papers | 183 | 183 |
| Total Cites to Single+First+Last Authored Papers | 5194 | 5670 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 6849 | 7220 |
| Ratio of Total Citations to Distinct Citing Papers | 1.31 | 1.36 |
| Self-Citation Percentage |
8.59%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.